---
title: "002022.SZ (002022.SZ) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/002022.SZ/news.md"
symbol: "002022.SZ"
name: "002022.SZ"
parent: "https://longbridge.com/zh-HK/quote/002022.SZ.md"
datetime: "2026-03-12T17:12:37.816Z"
locales:
  - [en](https://longbridge.com/en/quote/002022.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002022.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002022.SZ/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/002022.SZ/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/002022.SZ/news.md)


# 002022.SZ (002022.SZ) — 相關新聞

### [KHB: The company does not have products for the screening and diagnosis of chronic obstructive pulmonary disease (COPD)](https://longbridge.com/zh-HK/news/275845019.md)
*2026-02-13T03:38:47.000Z*
> An investor asked KHB on the interactive platform: Does the company have a screening and diagnostic product for COPD? KH

### [KHB: Expected net loss of RMB 580 million to RMB 740 million in 2025](https://longbridge.com/zh-HK/news/274281533.md)
*2026-01-30T09:21:16.000Z*
> KHB expects a net loss of RMB 580 million to RMB 740 million in 2025, an increase compared to the loss of RMB 641 millio

### [The monkeypox sector weakens, DAJY hits the limit down](https://longbridge.com/zh-HK/news/274098071.md)
*2026-01-29T06:08:06.000Z*
> The monkeypox sector weakened, with DAJY hitting the limit down, followed by declines in Hybribio Biotech, Bohui Innovat

### [KHB: The holding subsidiary Tianlong Company has a comprehensive solution for Nipah virus testing](https://longbridge.com/zh-HK/news/273953820.md)
*2026-01-28T08:00:44.000Z*
> 36Kr learned that KHB stated on the interactive platform that its holding subsidiary Tianlong Company has an overall sol

### [](https://longbridge.com/zh-HK/news/273649643.md)
*2026-01-26T05:15:09.000Z*
> The A-share biopharmaceutical sector continues to strengthen, with Maccura, Hybribio Biotech, and KHB hitting the daily 

### [](https://longbridge.com/zh-HK/news/273649301.md)
*2026-01-26T05:04:01.000Z*
> The A-share influenza sector surged again in the afternoon, with Hybribio Biotech hitting the daily limit, ZHIFEI-BIOL a

### [KHB: The holding subsidiary Suzhou Tianlong and the wholly-owned subsidiary Xi'an KHB have respectively received medical device registration certificates issued by the National Medical Products Administration and the Shaanxi Provincial Medical Products Administration](https://longbridge.com/zh-HK/news/273207015.md)
*2026-01-21T09:35:55.000Z*
> KHB announced that its holding subsidiary Suzhou Tianlong and wholly-owned subsidiary Xi'an KHB have respectively receiv

### [KHB obtained a medical device registration certificate](https://longbridge.com/zh-HK/news/271484808.md)
*2026-01-05T08:51:03.000Z*
> According to the Zhitong Finance APP, KHB announced that the company has received the medical device registration certif

### [KHB: Hepatitis A virus IgM antibody test kit has obtained medical device registration certificate](https://longbridge.com/zh-HK/news/271484797.md)
*2026-01-05T08:50:30.000Z*
> KHB announced that it recently received a medical device registration certificate issued by the National Medical Product